The Effect of Covid-19 Pandemic on Sarcopenia, Quality of Life and Pain: A One-Year Follow-Up Study

Bakılan, Fulya; Ozgen, Mihriban Heval; Ortanca, Burcu; Armağan, Onur; Ekim, Ayşe; Berkan, F. T.; Mutlu, Fezan

doi:10.31086/tjgeri.2021.230

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, 8 articles were included. [17][18][19][20][21][22][23][24] The flow chart of the literature screening and the results are presented in Figure 1.…”

Section: Search Resultsmentioning

confidence: 99%

“…There was no heterogeneity between the included studies (I 2 = 0%, P = .74), so a fixed-effect model was employed for the analysis. There was significant difference between the time before COVID-19 Bakilan 2021 [17] Cohort study pandemic group and during COVID-19 group (MD = -1.87, 95%CI = [-3.69, -0.05], Z = 2.01, P = .04) (Fig. 4).…”

Section: Body Weightmentioning

confidence: 93%

“…Two studies reported this outcome. A heterogeneity test showed that there was heterogeneity across studies (I 2 = 64%, Bakilan 2021 [17] * * * * ** * * 8 High Hasegawa 2021 [18] * * * ** * 6 Moderate Rocha 2021 [19] * * * * ** * 7 High Wierdsma 2021 [20] *…”

Section: Skeletal Muscle Mass Indexmentioning

confidence: 99%

See 2 more Smart Citations

Impact of the COVID-19 pandemic on risk of sarcopenia: From lockdown and infection perspectives: A systematic review and meta-analysis

Wang,

Guo,

Huang

et al. 2024

Medicine

View full text Add to dashboard Cite

Background: During the new coronavirus disease 2019 (COVID-19) pandemic, there are numerous symptoms in the skeletal muscular system, such as decreased skeletal muscle mass, strength, and muscle function, which are the main manifestations of sarcopenia. To investigate the impact of the COVID-19 pandemic on sarcopenia from the perspectives of COVID-19 pandemic lockdown and COVID-19 infection, we conducted this study. Methods: We searched for literature related to COVID-19 and sarcopenia published in PubMed, Embase, Cochrane Library, and Web of Science. Two researchers independently searched and screened the articles, extracted data, and assessed the quality of the final included literature. RevMan 5.4 was used for meta-analysis. Results: A total of 8 articles with a total of 1145 patients were included. There was a significant difference in SARC-F scores (MD = 0.67, 95%CI = [0.41, 0.93], Z = 5.00, P < .00001), handgrip (MD = ‐1.57, 95%CI = [‐2.41, ‐0.73], Z = 3.66, P = .0002), body weight (MD = ‐1.87, 95%CI = [‐3.69, ‐0.05], Z = 2.01, P = .04), and skeletal muscle mass index (MD = ‐0.28, 95%CI = [‐0.54, ‐0.02], Z = 2.13, P = .03) between the time before the COVID-19 pandemic and during the COVID-19 pandemic. However, the results showed that there was no significant difference in muscle mass between the 2 groups (MD = ‐1.72, 95%CI = [‐4.39, 0.94], Z = 1.27, P = .21). Conclusion: The COVID-19 pandemic has had an impact on sarcopenia. Both infection with COVID-19 and lockdown during the COVID-19 pandemic increase the risk of sarcopenia. Research should pay more attention to this disease during the COVID-19 pandemic and adopt effective interventions to minimize adverse outcomes.

show abstract

“…Finally, 8 articles were included. [17][18][19][20][21][22][23][24] The flow chart of the literature screening and the results are presented in Figure 1.…”

Section: Search Resultsmentioning

confidence: 99%

Section: Body Weightmentioning

confidence: 93%